Exercise Program (TEAM Me) for the Improvement of Movement and Mobility in Pediatric and Adolescent and Young Adult Patients With Cancer Undergoing a Blood Stem Cell Transplant

StatusActive, Not Recruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment closed, study ongoing Show 4 more changesShow less
    • Final enrollment: 30 participants (planned 60)
    • Eligibility criteria expanded, about 6 words
    • Secondary endpoints: details revised at 9 of 9 entries
    • Site details revised at 2 of 2 sites
  2. Primary and study completion dates: Dec 31, 2025 to Dec 31, 2028v10
  3. Site contacts updated at 1 of 2 sitesv9
  4. Site contacts updated at 1 of 2 sitesv8
  5. Re-verified, no change to tracked fieldsv7
Show 5 earlier versionsHide 5 earlier versions
  1. Study sites revised (2)v6
  2. 2 versions Re-verified since Jan 6, 2023, no change to tracked fieldsv4-v5
  3. Primary and study completion dates: Feb 28, 2024 to Dec 31, 2025v3
  4. Primary and study completion dates: Feb 1, 2022 to Feb 28, 2024v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This clinical trial studies how well an exercise program (Totally Excited About Moving, Mobility, and Exercise \[TEAM Me\]) affects the exercise and dietary habits of pediatric and adolescents and young adults with cancer undergoing a blood stem cell transplant. TEAM Me is an exercise program that reinforces behavior, such as walking and other activities, using "tokens" (i.e. stickers) that can be redeemed for rewards. Participating in the exercise program may result in increased physical fitness, physical activity level, quality of life, and function in pediatric and adolescents and young adult patients with cancer.
Trial Details
NCT Number NCT04678427
Lead Sponsor M.D. Anderson Cancer Center
Conditions
(from sponsor)		 Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm
Related terms Hematologic Neoplasms
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov